As of August 2022 Galmed Pharmaceuticals has a market cap of $0.01 Billion. This makes Galmed Pharmaceuticals the world's 6416th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $0.01 B | -75.78% |
2021 | $0.04 B | -31.12% |
2020 | $0.06 B | -45.75% |
2019 | $0.12 B | -14.89% |
2018 | $0.14 B | 14.35% |
2017 | $0.12 B | 194.4% |
2016 | $0.04 B | -49.52% |
2015 | $0.08 B | 31.21% |
2014 | $0.06 B |
On Aug 6th, 2022 the market cap of Galmed Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Evoke Pharma
EVOK | $0.01 B | -0.22% | ๐บ๐ธ USA |
![]() Endo International
ENDP | $0.16 B | 1,422.35% | ๐ฎ๐ช Ireland |
![]() Catalent CTLT | $19.81 B | 179,105.56% | ๐บ๐ธ USA |